A recent study, published in the BMJ, found that certain medications routinely prescribed for patients with type 2 diabetes may be associated with an increased risk of cholangiocarcinoma, a type of cancer which effects the bile ducts of the liver. The class of medications studied were are known as, DPP-4 inhibitors, and GLP-1 receptor antonists. …
Tag
Showing: 1 - 1 of 1 RESULTS